Annual EBITDA
$628.02 M
+$838.72 M+398.06%
December 31, 2024
Summary
- As of March 2, 2025, AHCO annual EBITDA is $628.02 million, with the most recent change of +$838.72 million (+398.06%) on December 31, 2024.
- During the last 3 years, AHCO annual EBITDA has risen by +$83.81 million (+15.40%).
- AHCO annual EBITDA is now at all-time high.
Performance
AHCO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$190.98 M
+$36.76 M+23.84%
December 31, 2024
Summary
- As of March 2, 2025, AHCO quarterly EBITDA is $190.98 million, with the most recent change of +$36.76 million (+23.84%) on December 31, 2024.
- Over the past year, AHCO quarterly EBITDA has increased by +$60.13 million (+45.95%).
- AHCO quarterly EBITDA is now at all-time high.
Performance
AHCO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$628.02 M
+$336.81 M+115.66%
December 31, 2024
Summary
- As of March 2, 2025, AHCO TTM EBITDA is $628.02 million, with the most recent change of +$336.81 million (+115.66%) on December 31, 2024.
- Over the past year, AHCO TTM EBITDA has increased by +$848.60 million (+384.71%).
- AHCO TTM EBITDA is now -0.28% below its all-time high of $629.79 million, reached on March 31, 2022.
Performance
AHCO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AHCO EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +398.1% | +46.0% | +384.7% |
| 3 y3 years | +15.4% | +40.1% | +15.4% |
| 5 y5 years | +684.9% | +2266.2% | +1181.8% |
AHCO EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +398.1% | at high | +153.4% | -0.3% | +384.3% |
| 5 y | 5-year | at high | +398.1% | at high | +153.4% | -0.3% | +384.3% |
| alltime | all time | at high | +398.1% | at high | +153.4% | -0.3% | +384.3% |
AdaptHealth EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $628.02 M(-398.1%) | $190.98 M(+23.8%) | $628.02 M(+115.7%) |
| Sep 2024 | - | $154.22 M(+1.5%) | $291.21 M(-231.8%) |
| Jun 2024 | - | $151.98 M(+16.1%) | -$220.89 M(+0.1%) |
| Mar 2024 | - | $130.85 M(-189.7%) | -$220.58 M(+4.7%) |
| Dec 2023 | -$210.70 M(-137.7%) | -$145.84 M(-59.3%) | -$210.70 M(-396.1%) |
| Sep 2023 | - | -$357.88 M(-335.0%) | $71.15 M(-87.6%) |
| Jun 2023 | - | $152.29 M(+8.2%) | $572.69 M(+4.2%) |
| Mar 2023 | - | $140.73 M(+3.5%) | $549.58 M(-1.6%) |
| Dec 2022 | $558.49 M(+2.6%) | $136.01 M(-5.3%) | $558.49 M(-0.1%) |
| Sep 2022 | - | $143.66 M(+11.2%) | $558.81 M(-3.6%) |
| Jun 2022 | - | $129.18 M(-13.7%) | $579.65 M(-8.0%) |
| Mar 2022 | - | $149.64 M(+9.8%) | $629.79 M(+15.7%) |
| Dec 2021 | $544.21 M | $136.33 M(-17.1%) | $544.21 M(+56.2%) |
| Sep 2021 | - | $164.49 M(-8.3%) | $348.33 M(+129.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $179.33 M(+180.0%) | $152.09 M(+1731.6%) |
| Mar 2021 | - | $64.05 M(-207.6%) | $8.30 M(-110.1%) |
| Dec 2020 | -$82.17 M(-202.7%) | -$59.54 M(+87.6%) | -$82.17 M(+464.6%) |
| Sep 2020 | - | -$31.75 M(-189.3%) | -$14.55 M(-134.0%) |
| Jun 2020 | - | $35.54 M(-234.5%) | $42.79 M(+86.7%) |
| Mar 2020 | - | -$26.42 M(-427.3%) | $22.92 M(-53.2%) |
| Dec 2019 | $80.01 M(-6585.3%) | $8.07 M(-68.5%) | $48.99 M(+21.1%) |
| Sep 2019 | - | $25.59 M(+63.3%) | $40.44 M(+180.8%) |
| Jun 2019 | - | $15.67 M(-4689.6%) | $14.40 M(-1058.4%) |
| Mar 2019 | - | -$341.40 K(-29.2%) | -$1.50 M(+21.8%) |
| Dec 2018 | -$1.23 M | -$482.00 K(+8.4%) | -$1.23 M(+64.1%) |
| Sep 2018 | - | -$444.80 K(+89.8%) | -$751.70 K(+144.9%) |
| Jun 2018 | - | -$234.40 K(+223.3%) | -$306.90 K(+323.3%) |
| Mar 2018 | - | -$72.50 K | -$72.50 K |
FAQ
- What is AdaptHealth annual EBITDA?
- What is the all time high annual EBITDA for AdaptHealth?
- What is AdaptHealth annual EBITDA year-on-year change?
- What is AdaptHealth quarterly EBITDA?
- What is the all time high quarterly EBITDA for AdaptHealth?
- What is AdaptHealth quarterly EBITDA year-on-year change?
- What is AdaptHealth TTM EBITDA?
- What is the all time high TTM EBITDA for AdaptHealth?
- What is AdaptHealth TTM EBITDA year-on-year change?
What is AdaptHealth annual EBITDA?
The current annual EBITDA of AHCO is $628.02 M
What is the all time high annual EBITDA for AdaptHealth?
AdaptHealth all-time high annual EBITDA is $628.02 M
What is AdaptHealth annual EBITDA year-on-year change?
Over the past year, AHCO annual EBITDA has changed by +$838.72 M (+398.06%)
What is AdaptHealth quarterly EBITDA?
The current quarterly EBITDA of AHCO is $190.98 M
What is the all time high quarterly EBITDA for AdaptHealth?
AdaptHealth all-time high quarterly EBITDA is $190.98 M
What is AdaptHealth quarterly EBITDA year-on-year change?
Over the past year, AHCO quarterly EBITDA has changed by +$60.13 M (+45.95%)
What is AdaptHealth TTM EBITDA?
The current TTM EBITDA of AHCO is $628.02 M
What is the all time high TTM EBITDA for AdaptHealth?
AdaptHealth all-time high TTM EBITDA is $629.79 M
What is AdaptHealth TTM EBITDA year-on-year change?
Over the past year, AHCO TTM EBITDA has changed by +$848.60 M (+384.71%)